Olema Pharmaceuticals
Price & Volume
Stats
See moreOpen | $10.62 |
Previous Close | $10.73 |
Day Range | $10.58-$10.84 |
52W Range | $6.65-$36.25 |
Market Cap | $947.5M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.17 |
News
See moreYahoo Finance • last month
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 3 months ago
How Olema Pharmaceuticals (OLMA) Is Adding Pipeline Depth Behind Its Palazestrant Breast Cancer Bet
Yahoo Finance • 4 months ago
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
Yahoo Finance • 4 months ago
Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.
About
CEO | Dr. Sean P. Bohen M.D., Ph.D. |
CFO | Mr. Jason O'Byrne M.B.A. |
Address | 780 Brannan Street, San Francisco, CA, United States, 94103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 150 |